PI3K/AKT/mTOR pathway and androgen receptor expression as potential therapeutic targets for triple-negative breast cancer.
2015 ◽
Vol 33
(15_suppl)
◽
pp. e12069-e12069
2018 ◽
Vol 36
(15_suppl)
◽
pp. e12662-e12662
◽
2016 ◽
Vol 52
(2)
◽
pp. 131-140
◽
2018 ◽
Vol 69
(2)
◽
pp. 157-168
◽